Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AND017 in Transfusion-Dependent and Non-Transfusion Dependent β-thalassemia
NCT06302491Phase 2Recruiting
- Sponsor
- Kind Pharmaceuticals LLC
- Start
- May 2024
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of AND017 in beta thalassemia, sponsored by Kind Pharmaceuticals LLC. Started May 2024; status: recruiting.
02
Drugs
AND017
03
Conditions
beta thalassemia
Beyond the preview
Go deeper on NCT06302491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06302491.